Low-dose rituximab should be used for treating MS in resource-limited settings : Commentary
| Errataetall: |
CommentOn: Mult Scler. 2022 Jun;28(7):1030-1032. - PMID 35437067 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Multiple sclerosis (Houndmills, Basingstoke, England) - 28(2022), 7 vom: 15. Juni, Seite 1032-1033 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cárcamo, Claudia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4F4X42SYQ6 |
|---|
| Anmerkungen: |
Date Completed 25.05.2022 Date Revised 14.06.2022 published: Print CommentOn: Mult Scler. 2022 Jun;28(7):1030-1032. - PMID 35437067 Citation Status MEDLINE |
|---|
| doi: |
10.1177/13524585221098612 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341305758 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341305758 | ||
| 003 | DE-627 | ||
| 005 | 20231226011454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/13524585221098612 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1137.xml |
| 035 | |a (DE-627)NLM341305758 | ||
| 035 | |a (NLM)35608104 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cárcamo, Claudia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Low-dose rituximab should be used for treating MS in resource-limited settings |b Commentary |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.05.2022 | ||
| 500 | |a Date Revised 14.06.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Mult Scler. 2022 Jun;28(7):1030-1032. - PMID 35437067 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 700 | 1 | |a Ciampi, Ethel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Multiple sclerosis (Houndmills, Basingstoke, England) |d 1997 |g 28(2022), 7 vom: 15. Juni, Seite 1032-1033 |w (DE-627)NLM09012992X |x 1477-0970 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:7 |g day:15 |g month:06 |g pages:1032-1033 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/13524585221098612 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2022 |e 7 |b 15 |c 06 |h 1032-1033 | ||